[HTML][HTML] SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease

R Menon, EA Otto, R Sealfon, V Nair, AK Wong… - Kidney international, 2020 - Elsevier
COVID-19 morbidity and mortality are increased in patients with diabetes and kidney
disease via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 …

SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.

R Menon, EA Otto, R Sealfon, V Nair, AK Wong… - Kidney …, 2020 - europepmc.org
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease

R Menon, EA Otto, R Sealfon, V Nair, AK Wong… - Kidney …, 2020 - hero.epa.gov
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

[HTML][HTML] SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease

R Menon, EA Otto, R Sealfon, V Nair, AK Wong… - Kidney …, 2020 - ncbi.nlm.nih.gov
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

[HTML][HTML] SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease

R Menon, EA Otto, R Sealfon, V Nair… - Kidney …, 2020 - kidney-international.org
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

SARS-CoV-2 receptor networks in diabetic and COVID-19 associated kidney disease

R Menon, EA Otto, R Sealfon, V Nair, AK Wong… - medRxiv, 2020 - medrxiv.org
COVID-19 morbidity and mortality is increased in patients with diabetes and kidney disease
via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) for …

SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.

R Menon, EA Otto, R Sealfon, V Nair, AK Wong… - 2020 - cabidigitallibrary.org
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease

R Menon, EA Otto, R Sealfon, V Nair… - Kidney …, 2020 - pubmed.ncbi.nlm.nih.gov
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease

R Menon, EA Otto, R Sealfon, V Nair… - Kidney …, 2020 - oar.princeton.edu
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

[PDF][PDF] SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease

ET Note - Kidney International, 2020 - academia.edu
COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with
diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …